| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Correction to Lancet Microbe 2022; 3: e173–83
|
|
|
|
3 |
5 |
p. e333
|
artikel
|
| 2 |
Extending political will into action in African LMICs: abating global antimicrobial resistance
|
Aruhomukama, Dickson
|
|
|
3 |
5 |
p. e327-e328
|
artikel
|
| 3 |
Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK
|
Cordery, Rebecca
|
|
|
3 |
5 |
p. e366-e375
|
artikel
|
| 4 |
Loci for prediction of penicillin and tetracycline susceptibility in Neisseria gonorrhoeae: a genome-wide association study
|
Mortimer, Tatum D
|
|
|
3 |
5 |
p. e376-e381
|
artikel
|
| 5 |
Microbiome therapy for recurrent Clostridioides difficile
|
Gilbert, Judith A
|
|
|
3 |
5 |
p. e334
|
artikel
|
| 6 |
Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
|
Li, Pengfei
|
|
|
3 |
5 |
p. e325-e326
|
artikel
|
| 7 |
Nirsevimab: a promising therapy for RSV
|
Venkatesan, Priya
|
|
|
3 |
5 |
p. e335
|
artikel
|
| 8 |
Persistent viral shedding after acute Lassa fever: thorough evidence arouses more noteworthy concerns
|
Ye, Wei
|
|
|
3 |
5 |
p. e329
|
artikel
|
| 9 |
Pneumonia surveillance with culture-independent metatranscriptomics in HIV-positive adults in Uganda: a cross-sectional study
|
Spottiswoode, Natasha
|
|
|
3 |
5 |
p. e357-e365
|
artikel
|
| 10 |
Post-recovery enhancement of anti-variant neutralisation after severe COVID-19
|
Lu, Yingying
|
|
|
3 |
5 |
p. e330-e331
|
artikel
|
| 11 |
Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review
|
Rhee, Soo-Yon
|
|
|
3 |
5 |
p. e392-e398
|
artikel
|
| 12 |
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
|
Guo, Li
|
|
|
3 |
5 |
p. e348-e356
|
artikel
|
| 13 |
Searching for new therapeutic options for the uncommon pathogen Mycobacterium chimaera: an open drug discovery approach
|
Cantillon, Daire
|
|
|
3 |
5 |
p. e382-e391
|
artikel
|
| 14 |
Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
|
Stone, Will
|
|
|
3 |
5 |
p. e336-e347
|
artikel
|
| 15 |
Survivability of H5N8 mixed wild bird droppings in different conditions
|
Zhang, Jiahao
|
|
|
3 |
5 |
p. e332
|
artikel
|
| 16 |
The Lancet Microbe at 2: what is past is prologue
|
The Lancet Microbe,
|
|
|
3 |
5 |
p. e324
|
artikel
|
Tijdschrift beschrijving